Published in PLoS One on April 13, 2017
Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis (2000) 15.05
Practical methods for incorporating summary time-to-event data into meta-analysis. Trials (2007) 14.51
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 7.41
Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA (2007) 3.03
Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol (2000) 2.93
Are homografts superior to conventional prosthetic valves in the setting of infective endocarditis involving the aortic valve? J Thorac Cardiovasc Surg (2016) 2.70
Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol (2012) 2.02
Infective endocarditis. Nat Rev Cardiol (2011) 1.77
Graft selection for aortic root replacement in complex active endocarditis: does it matter? Ann Thorac Surg (2011) 1.51
Surgery for infective endocarditis: who and when? Circulation (2010) 1.45
Prosthetic valve endocarditis: current approach and therapeutic options. Prog Cardiovasc Dis (2007) 1.41
Surgical management of endocarditis: the society of thoracic surgeons clinical practice guideline. Ann Thorac Surg (2011) 1.36
Homograft reconstruction of the aortic root for endocarditis with periannular abscess: a 17-year study. Eur J Cardiothorac Surg (2005) 1.30
Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. Ann Thorac Surg (2001) 1.20
Thirty-day mortality and long-term survival following surgery for prosthetic endocarditis: a study from the UK heart valve registry. Eur J Cardiothorac Surg (1998) 1.03
The prevalence of infective endocarditis after aortic valve replacement. J Thorac Cardiovasc Surg (1995) 1.00
Surgical treatment for active infective prosthetic valve endocarditis: 22-year single-centre experience. Eur J Cardiothorac Surg (2010) 0.96
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement. J Thorac Cardiovasc Surg (2006) 0.91
What type of valve replacement should be used in patients with endocarditis? Interact Cardiovasc Thorac Surg (2010) 0.87
Predictors of recurrence and reoperation for prosthetic valve endocarditis after valve replacement surgery for native valve endocarditis. J Thorac Cardiovasc Surg (2008) 0.87
Long-term outcome of infective endocarditis in non-intravenous drug users. Mayo Clin Proc (2008) 0.87
Aortic valve replacement for active infective endocarditis: 5-year survival comparison of bioprostheses, homografts and mechanical prostheses. Eur J Cardiothorac Surg (2009) 0.86
CardioPulse Articles. Eur Heart J (2015) 0.82
Outcomes of surgery in the treatment of isolated nonnative mitral valve infective endocarditis. J Thorac Cardiovasc Surg (2013) 0.77
Outcomes and prosthesis choice for active aortic valve infective endocarditis: analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg (2014) 0.77
One-year outcome following biological or mechanical valve replacement for infective endocarditis. Int J Cardiol (2014) 0.77
Results of mechanical prosthetic valve replacement in active valvular endocarditis. J Cardiovasc Surg (Torino) (1996) 0.77
Bioprosthetic versus mechanical valve replacement in patients with infective endocarditis. J Card Surg (1989) 0.77